Comparing Absorption of Dietary Phosphorus When Administering FOSRENOL® or RENVELA® in Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

April 20, 2009

Primary Completion Date

June 16, 2009

Study Completion Date

June 16, 2009

Conditions
Kidney Failure, Chronic
Interventions
DRUG

Lanthanum Carbonate

1 x 1000mg tablet

DRUG

Sevelamer

3 x 800mg tablets

Trial Locations (1)

90630

West Coast Clinical Trials, Cypress

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Shire

INDUSTRY